TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
PharmInfo i Uppsala AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
18
|
41
|
71 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
14
|
22
|
38 |
| EBITDA |
17
|
25
|
47 |
| Total assets |
251
|
270
|
295 |
| Current assets |
221
|
268
|
289 |
| Current liabilities |
9
|
18
|
21 |
| Equity capital |
228
|
235
|
255 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
90.8%
|
87.0%
|
86.4% |
| Turnover per employee |
18
|
41
|
71 |
| Profit as a percentage of turnover |
77.8%
|
53.7%
|
53.5% |
| Return on assets (ROA) |
5.6%
|
8.1%
|
12.9% |
| Current ratio |
2455.6%
|
1488.9%
|
1376.2% |
| Return on equity (ROE) |
6.1%
|
9.4%
|
14.9% |
| Change turnover |
-23
|
-24
|
71 |
| Change turnover % |
-57%
|
-37% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.